Literature DB >> 6930158

Expected and observed proportion of subjects excluded from paternity by blood phenotypes of a child and its mother in a sample of 171 families.

D Salmon, J Seger, C Salmon.   

Abstract

The proportion of exclusion for a given mother-child pair is the proportion of males excluded from the paternity of this child of a known mother and may be calculated given both the child's and mother's phenotypes and the population gene frequencies. Its expected value in the population is equal to the probability of exclusion, which expresses a laboratory's capability to exclude from paternity nonbiological fathers.In a sample of 171 families examined for 20 genetic systems at the National Blood Group Reference Laboratory, 25 exclusions of putative fathers were detected. The ranking by efficiency of the systems used in these exclusions fits the "expectation of their efficiency," and the average proportion of males excluded by the child's and mother's phenotypes is not different from the expected proportion. Additionally, the repetition of exclusions in an incompatible putative father-mother-child trio is not dependent on the overall proportion of males excluded by the mother and the child, but rather on some high values of the proportion of excluded men in some specific systems.Here, formulas and some factors modifying these parameters as well as a more efficient sequence of examinations to exclude paternity than has previously been used are given. Using this sequence, laboratories which carry out several analyses per day can work by levels of five examinations at a time, done in a particular order, to obtain a rather rapid exclusion of certain families.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6930158      PMCID: PMC1686070     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  [Phenotypic frequencies of SGPT and C3 fraction of complement in a Parisian population].

Authors:  J Seger; D Salmon
Journal:  Rev Fr Transfus Immunohematol       Date:  1977-06

2.  [The Ael phenotype: immunologic and genetic study].

Authors:  S Lanset; A Gerbal; G Liberge; C Ropartz; C Salmon
Journal:  Nouv Rev Fr Hematol       Date:  1970 May-Jun

3.  Exclusion of paternity: the current state of the art.

Authors:  R Chakraborty; M Shaw; W J Schull
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

4.  A note on the distribution of the number of exclusions to be expected in paternity testing.

Authors:  R Chakraborty; W J Schull
Journal:  Am J Hum Genet       Date:  1976-11       Impact factor: 11.025

5.  [ Gene frequencies in 17 polymorphism systems. Study on a sample of subjects living in the Paris region].

Authors:  D Salmon; J Yvart
Journal:  Rev Fr Transfus       Date:  1974-12

6.  [Frequency of genes corresponding to adenosine deaminase, 6-phosphogluconate dehydrogenase and esterase D polymorphism in the Parisian population].

Authors:  J Seger
Journal:  Rev Fr Transfus Immunohematol       Date:  1977-12

7.  PATER: a program for parenthood diagnosis.

Authors: 
Journal:  Comput Programs Biomed       Date:  1976-03

8.  Probability of paternity exclusion when relatives are involved.

Authors:  D B Salmon; J Brocteur
Journal:  Am J Hum Genet       Date:  1978-01       Impact factor: 11.025

9.  [Validation of paternity in a father-mother-child trio, by the use of genetic markers. Description of a program to aid in the decision. Determination of the optimal sequence of examinations].

Authors:  C l Chastang; D Salmon; F Grémy; J Seger; Ch Salmon
Journal:  Nouv Rev Fr Hematol       Date:  1978-04-14
  9 in total
  2 in total

1.  No fallacies in the formulation of the paternity index.

Authors:  M P Baur; R C Elston; H Gürtler; K Henningsen; K Hummel; H Matsumoto; W Mayr; J W Moris; L Niejenhuis; H Polesky
Journal:  Am J Hum Genet       Date:  1986-10       Impact factor: 11.025

Review 2.  Measuring paternal discrepancy and its public health consequences.

Authors:  Mark A Bellis; Karen Hughes; Sara Hughes; John R Ashton
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.